Author: Arvin Arvin
finnCap Research Company Notes – 16 October 2019
Categories: NewsfinnCap Research Company Notes – 16 October 2019 Mark BrEWER Destiny Pharma (DEST) : Corp Reinforcing the value of XF-73 Key data The results from a Phase I study of XF-73, which was independently conducted and sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institutes of Health
finnCap Research Company Notes – 15 October 2019
Categories: NewsfinnCap Research Company Notes – 15 October 2019 dotDigital (DOTD) : Corp Prelims to June – building on the pillars Key data Prelims to June indicate performance in line with expectations, with EBITDA of £14.7m (£15.0mE) delivered from revenue of £42.5m (£42.5mE) leading to adj.dil.EPS of 3.9p (3.4pE, outperformance due to a lower tax charge)
finnCap Research Company Notes – 14 October 2019
Categories: NewsfinnCap Research Company Notes – 14 October 2019 Jonathan wright Iofina (IOF) : Corp Q3 trading update Key data Another solid quarter from Iofina that puts it on track to deliver record iodine production this year. Iodine prices continue to rise, which should also drive record revenue and earnings for the company this year. Its
Selling Your Business: How do I find my exit?
Categories: BlogSelling Your Business: How do I find my exit? Peter Gray In the first of our series on exiting, we examine what makes the right conditions for the right exit, taking a first look at the four most common routes; trade sale, PE sale, refinancing and flotation. Selling a business ranks as one of the
Global trends and transactions in today’s food flavors industry
Categories: BlogGlobal trends and transactions in today’s food flavors industry Jonathan Buxton Oaklins’ specialist Michele Manetti gives us an overview of the food ingredients (FI) sector, looking at elements such as customer base and barriers to entry, as well as key global trends. He also examines a selected number of listed FI companies that have outperformed
Beauty is in the eye of the acquiror
Categories: BlogBeauty is in the eye of the acquiror An analysis of the acquisition by GPF Capital of beauty and household products company Quimi Romar highlights some of the trends currently influencing private equity M&A deals. Oaklins’ specialists José Falgás and Nicholas Walker reflect on the characteristics of this transaction as well as on key themes
Savor the benefits of healthy beverages
Categories: BlogSavor the benefits of healthy beverages Jonathan Buxton The global healthy beverages market has doubled in size over the last 15 years due to wellness trends, with strong growth expected to continue. Oaklins’ specialist Paolo Russo examines how fast-shifting consumer preferences have forced companies to innovate and introduce products with new features that blur traditional
M&A Trends in Petcare
M&A Trends in Petcare Jonathan Buxton Why the market is ripe for further merger and acquisition activity which could see a very different petcare sector emerge in the years to come. Petcare is one of the fastest growing areas of the consumer sector. Globally it’s a £100bn market, with the UK petcare sector now value
finnCap Tech Chat | Elvis on the Moon
Categories: BlogfinnCap Tech Chat | Elvis on the Moon I’m fascinated by the Law of Unintended Consequences. History is littered with examples; Wrigley was originally a maker of baking powder which started to include little bits of chewing gum to sell their product when people started buying pre-baked bread. Lego was a wooden toy company until
finnCap Research Company Notes – 11 October 2019
Categories: NewsfinnCap Research Company Notes – 11 October 2019 Andrew Darley Ideagen (IDEA) : Corp Bolt-on acquisition Key data Demonstrating execution of its successful combination of organic and acquired growth, Ideagen has acquired Optima Diagnostics, a London-based provider of a SaaS-based Health & Safety compliance solution with an 80-strong customer base including well-known names such as
